The distribution of alcohol-attributable healthcare encounters across the population of alcohol users in Ontario, Canada.
Alcohol use
Canada
Geoffrey Rose
Prevention paradox
Substance use
Universal policies
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Oct 2023
Oct 2023
Historique:
received:
08
05
2023
revised:
15
08
2023
accepted:
24
08
2023
medline:
11
9
2023
pubmed:
11
9
2023
entrez:
11
9
2023
Statut:
epublish
Résumé
Recent evidence suggests there may be no safe level of alcohol use as even low levels are associated with increased risk for harm. However, the magnitude of the population-level health burden from lower levels of alcohol use is poorly understood. The objective was to estimate the distribution of alcohol-attributable healthcare encounters (emergency department (ED) visits and hospitalizations) across the population of alcohol users aged 15+ in Ontario, Canada. Using the International Model of Alcohol Harms and Policies (InterMAHP) tool, wholly and partially alcohol-attributable healthcare encounters were estimated across alcohol users: (1) former (no past-year use); (2) low volume (≤67.3 g ethanol/week); (3) medium volume (>67.3-134.5 g ethanol/week for women and >67.3-201.8 g ethanol/week for men); and (4) high volume (>134.5 g ethanol/week for women and >201.8 g ethanol/week for men). The alcohol-attributable healthcare burden was distributed across the population of alcohol users. A small population of high volume users (23% of men, 13% of women) were estimated to have contributed to the greatest proportion of alcohol-attributable healthcare encounters, particularly among men (men: 65% of ED visits and 71% of hospitalizations, women: 49% of ED visits and 50% of hospitalizations). The 71% of women low and medium volumes users were estimated to have contributed to a substantial proportion of alcohol-attributable healthcare encounters (47% of ED visits and 34% of hospitalizations). Findings provide support for universal alcohol policies (i.e., delivered to the entire population) for reducing population-level alcohol-attributable harm in addition to targeted policies for high-risk users.
Identifiants
pubmed: 37691889
doi: 10.1016/j.pmedr.2023.102388
pii: S2211-3355(23)00279-6
pmc: PMC10491731
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102388Informations de copyright
Crown Copyright © 2023 Published by Elsevier Inc.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Int J Epidemiol. 2010 Apr;39(2):372-7
pubmed: 19887510
Drug Alcohol Depend. 2015 Nov 1;156:1-13
pubmed: 26371405
Lancet Public Health. 2020 Jan;5(1):e51-e61
pubmed: 31910980
Addiction. 2012 Jan;107(1):60-8
pubmed: 21752142
Drug Alcohol Rev. 2023 May;42(4):926-937
pubmed: 36843065
BMC Public Health. 2019 Oct 22;19(1):1323
pubmed: 31640654
Addiction. 2006 Jan;101(1):84-90
pubmed: 16393194
J Stud Alcohol Drugs. 2007 May;68(3):345-52
pubmed: 17446973
Lancet Gastroenterol Hepatol. 2019 Dec;4(12):913-933
pubmed: 31648977
J Stud Alcohol Drugs. 2020 May;81(3):339-351
pubmed: 32527386
Addiction. 2016 Jul;111(7):1293-8
pubmed: 27073140
J Stud Alcohol Drugs. 2021 Jan;82(1):9-17
pubmed: 33573718
CMAJ. 2011 Mar 8;183(4):450-5
pubmed: 21324848
Lancet. 2018 Sep 22;392(10152):1015-1035
pubmed: 30146330
Biomed Res Int. 2014;2014:853410
pubmed: 25057502
Int J Epidemiol. 1985 Mar;14(1):32-8
pubmed: 3872850
Addiction. 2021 Sep;116(9):2372-2384
pubmed: 33651444
J Stud Alcohol Drugs. 2020 May;81(3):352-361
pubmed: 32527387